Christopher B. Granger

125.7k total citations · 38 hit papers
846 papers, 63.9k citations indexed

About

Christopher B. Granger is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Christopher B. Granger has authored 846 papers receiving a total of 63.9k indexed citations (citations by other indexed papers that have themselves been cited), including 683 papers in Cardiology and Cardiovascular Medicine, 164 papers in Surgery and 138 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Christopher B. Granger's work include Acute Myocardial Infarction Research (352 papers), Atrial Fibrillation Management and Outcomes (243 papers) and Cardiac Imaging and Diagnostics (138 papers). Christopher B. Granger is often cited by papers focused on Acute Myocardial Infarction Research (352 papers), Atrial Fibrillation Management and Outcomes (243 papers) and Cardiac Imaging and Diagnostics (138 papers). Christopher B. Granger collaborates with scholars based in United States, Canada and United Kingdom. Christopher B. Granger's co-authors include Salim Yusuf, John J.V. McMurray, Karl Swedberg, Marc A. Pfeffer, Eric L. Michelson, Jan Östergren, Bertil Olofsson, Peter Held, Paul W. Armstrong and Eric J. Topol and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Christopher B. Granger

813 papers receiving 61.5k citations

Hit Papers

Effects of candesartan in patients with chronic heart fai... 1996 2026 2006 2016 2003 2003 2003 2003 2018 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
    2003 2.0k citations Salim Yusuf, Marc A. Pfeffer et al. profile →
  2. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
    2003 1.8k citations John J.V. McMurray, Jan Östergren et al. profile →
  3. Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events
    2003 1.7k citations Christopher B. Granger profile →
  4. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme
    2003 1.3k citations Marc A. Pfeffer, Karl Swedberg et al. profile →
  5. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
    2018 1.2k citations Sana M. Al‐Khatib, Christopher B. Granger et al. Journal of the American College of Cardiology profile →
  6. A Validated Prediction Model for All Forms of Acute Coronary Syndrome
    2004 1.2k citations Robert J. Goldberg, Shaun G. Goodman et al. JAMA profile →
  7. Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
    2001 1.2k citations Christopher B. Granger et al. profile →
  8. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)
    2006 1.1k citations Keith A.A. Fox, Robert J. Goldberg et al. profile →
  9. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial
    2003 1.1k citations Christopher B. Granger, John J.V. McMurray et al. profile →
  10. Embolic strokes of undetermined source: the case for a new clinical construct
    2014 1.1k citations Christopher B. Granger et al. profile →
  11. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
    2016 1.0k citations Christopher B. Granger et al. Journal of the American College of Cardiology profile →
  12. Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
    2013 948 citations John W. Eikelboom, Stuart J. Connolly et al. profile →
  13. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery
    2016 895 citations Christopher B. Granger et al. Circulation profile →
  14. Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia
    1996 859 citations Paul W. Armstrong, Christopher B. Granger et al. profile →
  15. Heparin and Low-Molecular-Weight Heparin
    1998 817 citations Christopher B. Granger et al. profile →
  16. Predictors of mortality and morbidity in patients with chronic heart failure
    2005 757 citations Stuart Pocock, Duolao Wang et al. European Heart Journal profile →
  17. Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure
    2007 752 citations Stuart Pocock, John J.V. McMurray et al. Journal of the American College of Cardiology profile →
  18. Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure
    2006 733 citations Marc A. Pfeffer, Karl Swedberg et al. Circulation profile →
  19. Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006
    2007 627 citations Keith A.A. Fox, Philippe Gabríel Steg et al. JAMA profile →
  20. Influence of Ejection Fraction on Cardiovascular Outcomes in a Broad Spectrum of Heart Failure Patients
    2005 609 citations Scott D. Solomon, Hicham Skali et al. Circulation profile →
  21. Early versus Delayed Invasive Intervention in Acute Coronary Syndromes
    2009 582 citations Christopher B. Granger, Philippe Gabríel Steg et al. profile →
  22. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary
    2017 472 citations Sana M. Al‐Khatib, Christopher B. Granger et al. Journal of the American College of Cardiology profile →
  23. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
    2017 465 citations Sana M. Al‐Khatib, Christopher B. Granger et al. Circulation profile →
  24. Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure
    2007 457 citations Scott D. Solomon, Joanna Dobson et al. Circulation profile →
  25. Fundamentals of Clinical Trials
    2015 455 citations Christopher B. Granger et al. profile →
  26. Relationship Between Infarct Size and Outcomes Following Primary PCI
    2016 425 citations Gregg W. Stone, Harry P. Selker et al. Journal of the American College of Cardiology profile →
  27. Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
    2012 422 citations Stefan H. Hohnloser, Ziad Hijazi et al. European Heart Journal profile →
  28. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary
    2017 418 citations Sana M. Al‐Khatib, Christopher B. Granger et al. profile →
  29. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
    2017 384 citations Sana M. Al‐Khatib, Christopher B. Granger et al. profile →
  30. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
    2016 330 citations Ziad Hijazi, Jonas Oldgren et al. profile →
  31. Association of Bystander and First-Responder Intervention With Survival After Out-of-Hospital Cardiac Arrest in North Carolina, 2010-2013
    2015 298 citations Kristian Kragholm, Lisa Monk et al. JAMA profile →
  32. Post-Myocardial Infarction Heart Failure
    2018 292 citations Christopher B. Granger et al. profile →
  33. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials
    2017 289 citations Suzanne de Waha, Manesh R. Patel et al. European Heart Journal profile →
  34. The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation
    2016 284 citations Ziad Hijazi, Johan Lindbäck et al. European Heart Journal profile →
  35. Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study
    2018 277 citations Christopher B. Granger, Kenneth W. Mahaffey et al. American Heart Journal profile →
  36. Heart Failure with Mid-Range Ejection Fraction in CHARM: Characteristics, Outcomes and Effect of Candesartan Across the Entire Ejection Fraction Spectrum
    2018 276 citations Pardeep S. Jhund, Karl Swedberg et al. European Journal of Heart Failure profile →
  37. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary
    2017 276 citations Sana M. Al‐Khatib, Christopher B. Granger et al. Circulation profile →
  38. Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials
    2023 100 citations Alexander P. Benz, Jeff S. Healey et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher B. Granger United States 119 49.5k 13.8k 10.0k 7.3k 5.6k 846 63.9k
Harvey D. White New Zealand 99 45.2k 0.9× 21.6k 1.6× 14.0k 1.4× 5.8k 0.8× 3.8k 0.7× 719 57.9k
Bernard J. Gersh United States 138 61.8k 1.2× 19.2k 1.4× 13.7k 1.4× 5.1k 0.7× 7.2k 1.3× 1.1k 76.6k
Elliott M. Antman United States 108 49.4k 1.0× 17.3k 1.3× 11.3k 1.1× 9.6k 1.3× 3.9k 0.7× 527 61.0k
Eugene Braunwald United States 104 43.0k 0.9× 20.7k 1.5× 12.5k 1.3× 4.5k 0.6× 4.2k 0.7× 448 59.7k
Keith A.A. Fox United Kingdom 109 47.7k 1.0× 15.5k 1.1× 11.2k 1.1× 12.1k 1.7× 4.8k 0.9× 834 59.8k
Eric D. Peterson United States 142 46.9k 0.9× 21.4k 1.6× 8.0k 0.8× 6.2k 0.9× 17.3k 3.1× 1.2k 79.8k
David A. Morrow United States 100 29.5k 0.6× 12.8k 0.9× 9.2k 0.9× 2.6k 0.4× 5.0k 0.9× 592 45.0k
Allan S. Jaffe United States 99 38.7k 0.8× 13.6k 1.0× 13.9k 1.4× 2.4k 0.3× 3.9k 0.7× 622 51.4k
Philippe Gabríel Steg France 123 56.5k 1.1× 30.1k 2.2× 10.3k 1.0× 9.6k 1.3× 5.6k 1.0× 1.1k 77.2k
Joseph S. Alpert United States 67 37.7k 0.8× 11.9k 0.9× 12.0k 1.2× 4.3k 0.6× 4.2k 0.7× 348 48.1k

Countries citing papers authored by Christopher B. Granger

Since Specialization
Citations

This map shows the geographic impact of Christopher B. Granger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher B. Granger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher B. Granger more than expected).

Fields of papers citing papers by Christopher B. Granger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher B. Granger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher B. Granger. The network helps show where Christopher B. Granger may publish in the future.

Co-authorship network of co-authors of Christopher B. Granger

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher B. Granger. A scholar is included among the top collaborators of Christopher B. Granger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher B. Granger. Christopher B. Granger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaltenbach, Lisa A., Daniel B. Mark, Audrey L. Blewer, et al.. (2025). Public awareness of automated external defibrillator (AED)s and their location: Results of a cross-sectional survey in North Carolina. Resuscitation Plus. 22. 100897–100897.
2.
Zagorski, Brandon, Tauben Averbuch, Rodrigo Bagur, et al.. (2025). Long-Term Healthcare Utilization and Outcomes in Patients Hospitalized for Heart Failure With and Without Atrial Fibrillation. The American Journal of Cardiology. 256. 115–124. 1 indexed citations
3.
Johnson, Linda, Alexander P. Benz, Ashkan Shoamanesh, et al.. (2024). Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient‐Level Meta‐Analysis From COMBINE AF. Journal of the American Heart Association. 13(17). e034758–e034758. 3 indexed citations
4.
Pun, Patrick H., Konstantin A. Krychtiuk, Christopher B. Granger, et al.. (2024). Public access defibrillator locations and details in Forsyth County, North Carolina: Results of a telephone survey canvas of large businesses to facilitate out-of-hospital cardiac arrest treatment. The American Journal of Emergency Medicine. 85. 166–171.
5.
Shen, Li, Matthew M.Y. Lee, Pardeep S. Jhund, et al.. (2024). Revisiting Race and the Benefit of RAS Blockade in Heart Failure. JAMA. 331(24). 2094–2094. 2 indexed citations
6.
Waha, Suzanne de, Manesh R. Patel, Hölger Thiele, et al.. (2024). Relationship Between Infarct Artery, Myocardial Injury, and Outcomes After Primary Percutaneous Coronary Intervention in ST‐Segment–Elevation Myocardial Infarction. Journal of the American Heart Association. 13(18). e034748–e034748. 5 indexed citations
7.
Haller, Paul M., Petr Jarolı́m, Andrea Bellavia, et al.. (2024). Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation. Journal of the American College of Cardiology. 84(16). 1528–1540. 7 indexed citations
8.
Benz, Alexander P., Stefan H. Hohnloser, John W. Eikelboom, et al.. (2023). Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation. European Heart Journal. 44(20). 1807–1814. 23 indexed citations
9.
Redfors, Björn, Reza Mohebi, Gennaro Giustino, et al.. (2021). Time Delay, Infarct Size, and Microvascular Obstruction After Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction. Circulation Cardiovascular Interventions. 14(2). e009879–e009879. 34 indexed citations
10.
Held, Claes, Nermin Hadziosmanovic, Johan Lindbäck, et al.. (2021). Risk markers of incident atrial fibrillation in patients with coronary heart disease. American Heart Journal. 233. 92–101. 6 indexed citations
11.
Shavadia, Jay, DaJuanicia N. Holmes, Laine Thomas, et al.. (2019). Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly Patients. Circulation Cardiovascular Quality and Outcomes. 12(7). e005103–e005103. 18 indexed citations
12.
Rohla, Miklós, Ioannis Tentzeris, Matthias K. Freynhofer, et al.. (2015). Long-term mortality of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation for acute and stable coronary artery disease. International Journal of Cardiology. 184. 108–114. 19 indexed citations
13.
Fosbøl, Emil Loldrup, Christopher B. Granger, James G. Jollis, et al.. (2012). The Impact of a Statewide Pre-Hospital STEMI Strategy to Bypass Hospitals Without Percutaneous Coronary Intervention Capability on Treatment Times. Circulation. 127(5). 604–612. 82 indexed citations
14.
Szczech, Lynda A., Christopher B. Granger, Joseph F. Dasta, et al.. (2010). Acute Kidney Injury and Cardiovascular Outcomes in Acute Severe Hypertension. Circulation. 121(20). 2183–2191. 44 indexed citations
15.
Hawkins, Nathaniel M., Duolao Wang, John J.V. McMurray, et al.. (2007). Prevalence and Prognostic Impact of Bundle Branch Block in Patients with Heart Failure: Evidence from the CHARM Programme. European Journal of Heart Failure. 9(5). 510–517. 45 indexed citations
16.
Spencer, Frederick A., Mauro Moscucci, Christopher B. Granger, et al.. (2007). Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction?. Circulation. 116(24). 2793–2801. 180 indexed citations
17.
Solomon, Scott D., Joanna Dobson, Stuart Pocock, et al.. (2007). Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure. Circulation. 116(13). 1482–1487. 457 indexed citations breakdown →
18.
Lewis, Eldrin F., Gervasio A. Lamas, Eileen O’Meara, et al.. (2006). Characterization of Health-Related Quality of Life in Heart Failure Patients with Preserved Versus Low Ejection Fraction in CHARM. European Journal of Heart Failure. 9(1). 83–91. 179 indexed citations
19.
Armstrong, Paul W., Kenneth W. Mahaffey, Wei-Ching Chang, et al.. (2006). Concerning the mechanism of pexelizumab's benefit in acute myocardial infarction. American Heart Journal. 151(4). 787–790. 15 indexed citations
20.
Brener, Sorin J., Stephen G. Ellis, Shelly Sapp, et al.. (2000). Predictors of death and reinfarction at 30 days after primary angioplasty: The GUSTO Ilb and RAPPORT trials. American Heart Journal. 139(3). 476–481. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harvey D. White Breakdown of academic impact, for papers by Bernard J. Gersh Breakdown of academic impact, for papers by Elliott M. Antman Breakdown of academic impact, for papers by Eugene Braunwald Breakdown of academic impact, for papers by Keith A.A. Fox Breakdown of academic impact, for papers by Eric D. Peterson Breakdown of academic impact, for papers by David A. Morrow Breakdown of academic impact, for papers by Allan S. Jaffe Breakdown of academic impact, for papers by Philippe Gabríel Steg Breakdown of academic impact, for papers by Joseph S. Alpert
Rankless by CCL
2026